Geneos Wealth Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18K | Sell |
327
-339
| -51% | -$18.6K | ﹤0.01% | 2079 |
|
|
2025
Q1 | $47.1K | Buy |
666
+580
| +674% | +$41K | ﹤0.01% | 1956 |
|
|
2024
Q4 | $5.65K | Sell |
86
-4
| -4% | -$263 | ﹤0.01% | 2289 |
|
|
2024
Q3 | $6.33K | Buy |
+90
| New | +$6.33K | ﹤0.01% | 1990 |
|
|
2024
Q2 | – | Sell |
-24
| Closed | -$2.1K | – | 2069 |
|
|
2024
Q1 | $2.1K | Buy |
+24
| New | +$2.1K | ﹤0.01% | 1892 |
|
|
2021
Q2 | – | Sell |
-1,277
| Closed | -$99K | – | 2875 |
|
|
2021
Q1 | $99K | Buy |
+1,277
| New | +$99K | ﹤0.01% | 1315 |
|
|
2019
Q2 | – | Sell |
-49
| Closed | -$4K | – | 2490 |
|
|
2019
Q1 | $4K | Hold |
49
| – | – | ﹤0.01% | 2073 |
|
|
2018
Q4 | $4K | Buy |
49
+19
| +63% | +$1.55K | ﹤0.01% | 2026 |
|
|
2018
Q3 | $2K | Hold |
30
| – | – | ﹤0.01% | 2236 |
|
|
2018
Q2 | $2K | Hold |
30
| – | – | ﹤0.01% | 2089 |
|
|
2018
Q1 | $2K | Hold |
30
| – | – | ﹤0.01% | 2012 |
|
|
2017
Q4 | $2K | Hold |
30
| – | – | ﹤0.01% | 2004 |
|
|
2017
Q3 | $2K | Hold |
30
| – | – | ﹤0.01% | 1952 |
|
|
2017
Q2 | $2K | Hold |
30
| – | – | ﹤0.01% | 1904 |
|
|
2017
Q1 | $2K | Sell |
30
-13
| -30% | -$867 | ﹤0.01% | 1860 |
|
|
2016
Q4 | $3K | Hold |
43
| – | – | ﹤0.01% | 1741 |
|
|
2016
Q3 | $3K | Sell |
43
-7
| -14% | -$488 | ﹤0.01% | 1676 |
|
|
2016
Q2 | $4K | Hold |
50
| – | – | ﹤0.01% | 1550 |
|
|
2016
Q1 | $4K | Buy |
+50
| New | +$4K | ﹤0.01% | 1529 |
|